DiPT, is one of the most mysterious compounds in the world of psychedelics. Synthesized in the 1990s and briefly popular in underground circles, it was said to induce vivid auditory distortions and ...

Nial Wheate in the past has received funding from the ACT Cancer Council, Tenovus Scotland, Medical Research Scotland, Scottish Crucible, and the Scottish Universities Life Sciences Alliance. He is a ...

The U.S. Food and Drug Administration will soon approve leucovorin for children with cerebral folate deficiency and autism symptoms Research suggests the drug may improve verbal skills, but it is not ...

The Food and Drug Administration plans to approve a new use for the generic drug leucovorin in the coming weeks to treat kids with “cerebral folate deficiency and autistic symptoms,” according to a ...

The Dominican Republic has indicated that a boat targeted by a U.S. airstrike had been ferrying "approximately 1,000 kilograms of suspected cocaine." That figure converts to more than 2,200 pounds, ...

The U.S. Food and Drug Administration has approved a version of leucovorin made by GlaxoSmithKline, years after the company pulled the drug from consideration when it stopped manufacturing it. The ...

WASHINGTON—The Food and Drug Administration moved to approve a version of a little-known medicine that the Trump administration is planning to tout as a treatment for autism symptoms, according to a ...

The F.D.A. announced Monday that it would change the drug’s label to reflect potential benefits in reducing autism symptoms. By Christina Caron Dr. Marty Makary, the commissioner of the Food and Drug ...

While Ozempic and other drugs like it have proven effective in helping people lose weight, many gain it back when the injections stop. A new drug targets weight loss differently, leading to a more ...

White House officials are considering launching a website that would allow Americans to purchase cheaper prescription drugs directly from pharmaceutical companies, according to a report from Bloomberg ...

One of neurologist Anelyssa D’Abreu’s least favorite tasks is giving her patients a dreaded diagnosis: early-stage Alzheimer’s disease. But it’s not quite as bad as it used to be. Today when they ask, ...